References
Ito Y, Tomoda C, Urono T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121
Ito Y, Miyauchi A (2007) Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid. Expert Opin Pharmacother 8:3205–3215
Ito Y, Miyauchi A (2007) A therapeutic strategy for the incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240–248
Ito Y, Masuoka H, Fukushima M et al (2010) Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg 34. doi:10.1007/s00268-009-0356-0
Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803
Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Mazzaferri EL (2009) A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine. J Clin Endocrinol Metab 94:1086–1088
Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689
Stulak JM, Grant CS, Farley DR et al (2006) Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489–494
Grant CS, Stulak JM, Thompson GB et al (2009) The risk and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999–2006. World J Surg 33:S125. doi:10.1007/s00268-009-0307-9
Hay ID (2007) Management of patients with low-risk papillary thyroid cancer. Endocr Pract 13:521–533
Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid cancer. J Surg Oncol 94:692–700
Hay ID, McDougall IR, Sisson JC (2008) Perspective: the case against radioiodine remnant ablation in patients with differentiated thyroid carcinoma. J Nucl Med 49:1395–1397
Noguchi S, Yamashita H, Uchino S et al (2008) Papillary microcarcinoma. World J Surg 32:747–753
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hay, I.D. Managing Patients with a Preoperative Diagnosis of AJCC/UICC Stage I (T1N0M0) Papillary Thyroid Carcinoma: East Versus West, Whose Policy is Best?. World J Surg 34, 1291–1293 (2010). https://doi.org/10.1007/s00268-010-0469-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-010-0469-5